Inhibikase Therapeutics, Inc. · NASDAQ:IKT

Commodore Capital LP reported a 9.90% stake in Inhibikase Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Commodore Capital LP reported a 9.90% stake in Inhibikase Therapeutics, Inc., 14,054,940 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
14,054,940
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Commodore Capital LP9.90%14,054,940
Commodore Capital Master LP9.90%14,054,940
Robert Egen Atkinson9.90%14,054,940
Michael Kramarz9.90%14,054,940

Source

View original at SEC

Related